ResMed Sees Sleep and Respiratory Leadership Change
Sleep and Respiratory Care President Jim Hollingshead steps down to leave the company, with President and Chief Operating Officer Rob Douglas filling the slot on an interim basis.
Jim Hollingshead has stepped down from his role as ResMed’s president of Sleep and Respiratory Care to accept a new position outside the company.
While ResMed finds a replacement, President and Chief Operating Officer Rob Douglas has stepped in as the interim president of Sleep and Respiratory Care.
“I’d like to thank Jim for his 12 years of service and valuable contributions to ResMed,” said Mick Farrell, ResMed CEO. “Jim has played an important role in our business, first as head of our strategy and business development team, then as president of our Americas region, and most recently as president of our Sleep and Respiratory Care business.”
Hollingshead formed part of the global business team that created the strategy to embed communications in ResMed’s devices to help ResMed become a digital health company.
“Together with our CEO operations team, Jim has helped curate a team of strong leaders, leaving ResMed well positioned for ongoing growth as we accelerate our business into 2025 and beyond,” Farrell added. “I wish Jim well in his new role as a ResMed alum, and I thank Rob for stepping in on an interim basis, as together we build upon our strong leadership bench-strength here at ResMed.”